Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this study is to determine the safety and effectiveness of the HeartWare Ventricular Assist System in patients with chronic Stage D/ New York Heart Association (NYHA) Class IIIB/IV left ventricular failure who have received and failed optimal medical therapy, and who are ineligible for cardiac transplantation.

Official Title

A Prospective, Randomized, Controlled, Un-blinded, Multi-Center Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (VAS) for Destination Therapy of Advanced Heart Failure

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Philip Oyer
Philip Oyer
Heart transplant surgeon
Roy B. Cohn-Theodore A. Falasco Professor of Cardiothoracic Surgery, Emeritus

Contact us to find out if this trial is right for you.


Philip Oyer
(650) 725-3820